Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Analysis of the treatment of neuromyelitis optica.
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
Risk of venous thrombosis in patients with major illnesses: Results from the MEGA study.
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Hospital admission due to infections in multiple sclerosis patients.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
B cells in MS and NMO: pathogenesis and therapy.
[Oculomotor system and multiple sclerosis.]
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.
Adrenergic regulation of innate immunity: a review.
Monitoring game-based motor rehabilitation of patients at home for better plans of care and quality of life.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
A profile of childhood neuropathies at a university hospital in Oman.
Anxiety state affects information processing speed in patients with multiple sclerosis.
Pages
« first
‹ previous
…
541
542
543
544
545
546
547
548
549
…
next ›
last »